HK StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Core Assets of Southward Funds

1,123.620

-2.229-0.20%

Number of Gainers:21

Number of Losers:40

Number of Flat:6

PE:- -

High:1,130.772

Open:1,125.841

Low:1,108.835

Close:1,125.849

Loading ...

Cryptocurrency Exchange Platform Rails Raises $14 Million in Funding with Participation from Kraken

ANTA Sports Products Limited Announces New Share Award Scheme Granting 10.45 Million Shares to Employees

Minth Group Limited Announces New Executive Director and Changes in Independent Non-Executive Directors

China Mengniu Dairy Files Next Day Disclosure to HKEX: Repurchases 200,000 Shares for HKD 3,598,260

Shandong Weigao Group Medical Polymer Co. Ltd. Buys Back 140,000 Shares for HKD 800,800

Indonesian policyholders must pay part of medical insurance claims from 2026

Innovent's Phase 1 Trial for Lung Cancer Drug Shows Manageable Safety, Long-Term Survival Benefits; Shares Surge 14%

MT Newswires Live

BUZZ-Hansoh hits near 4-year peak as its cancer drug gets UK marketing approval

Hansoh Pharmaceutical's Aumolertinib Mesilate Tablets Approved by UK MHRA for Marketing

Hansoh Pharmaceutical - Aumolertinib Mesilate Tablets Was Approved by Mhra for Marketing

THOMSON REUTERS

Zhongyu Energy Holdings Limited Announces Executive Management Changes: Li Yan Resigns, Peng Jun and Wang Jichao Appointed

Sino Biopharm Presents Lung Cancer Study Data at American Oncology Conference

MT Newswires Live

Xinyi Solar Holdings Ltd. Announces Proposed PRC Listing for Selected Solar Farm Projects via Infrastructure REIT

China's Xiaomi Founder Expects EV Business to Turn Profitable in H2

China's Xiaomi:Founder Expects Xiaomi's Auto Business to Turn Profitable in H2

THOMSON REUTERS

Market Chatter: Macau's Hotel Room Shortage Hinders City's Growth, Galaxy Chairman Says

MT Newswires Live

Innovent Biologics Announces Promising Phase 1/2 Results for IBI354 in Advanced Solid Tumors at 2025 ASCO Meeting

Haidilao founder, Ray Dalio, Forrest Li’s wife among ultra-rich splurging on 8-figure Singapore properties

Hansoh Pharmaceutical Signs $80 Million License Agreement with Regeneron for Drug Development

Hansoh Pharmaceutical - Licensors Will Receive an Upfront Payment of US$80 Mln and Be Eligible to Receive up to US$1.93 Bln in Milestone Payments

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BK1589/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1589","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1589\",,,,,undefined,":{"symbol":"BK1589","market":"HK","secType":"PLATE","nameCN":"Core Assets of Southward Funds","latestPrice":1123.62,"timestamp":1749197315293,"preClose":1125.8485,"halted":0,"volume":1909162160,"delay":0,"changeRate":-0.001979,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Market Closed","change":-2.228516,"latestTime":"06-06 16:00:00","open":1125.8408,"high":1130.7719,"low":1108.8348,"amount":50411219924.9,"amplitude":0.019485,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1749432600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1749173400000,1749182400000],[1749186000000,1749196800000]],"pbRate":2.106,"peRate":17.544731,"turnoverRate":0.003411,"increases":20,"decrements":44,"flats":3,"marketCap":15678420809216,"floatMarketCap":14660641200640},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1589\",,,,,undefined,":{"symbol":"BK1589","high":1130.7719,"amplitude":0.019485,"preClose":1125.8485,"low":1108.8348,"pbRate":"2.106","latestPrice":1123.62,"volume":1909162160,"delay":0,"open":1125.8408,"prevYearClose":949.2231,"prevWeekClose":1095.019,"prevMonthClose":1095.019,"prevQuarterClose":1071.805,"fiveDayClose":1095.019,"twentyDayClose":1067.642,"sixtyDayClose":1138.122,"secType":"PLATE","market":"HK","turnoverRate":0.003411,"peRate":17.544731,"marketCap":15678420809216,"floatMarketCap":14660641200640,"timestamp":1749197315293,"nameCN":"Core Assets of Southward Funds"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1589\",,,,undefined,":{"bkCode":"BK1589","up":21,"down":40,"flat":6},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1589\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2540069604","title":"Cryptocurrency Exchange Platform Rails Raises $14 Million in Funding with Participation from Kraken","url":"https://stock-news.laohu8.com/highlight/detail?id=2540069604","media":"Blockbeats","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540069604?lang=en_us&edition=fundamental","pubTime":"2025-06-04 21:06","pubTimestamp":1749042360,"startTime":"0","endTime":"0","summary":"BlockBeats News, June 4th, According to Coindesk, the cryptocurrency exchange platform Rails has completed a $14 million financing round. This round of financing was led by Kraken, Slow Ventures, CMCC Global, Quantstamp, and Round13 Capital. The funding will be used to launch a trading platform that combines self-custody with high-speed execution.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theblockbeats.info//en/flash/296858","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"theblockbeats_live","symbols":["LU0531971595.HKD","80883","LU0039217434.USD","BK1589","LU1226287792.SGD","00941","LU0149721374.USD","LU1226288253.USD","LU0871576103.HKD","BK1521","SG9999002463.SGD","BK1506","LU1481107354.HKD","LU1226288170.HKD","LU1951186391.HKD","BK1152","LU1497733631.SGD","LU1522347837.USD","LU1226287875.USD","LU1634259391.SGD","LU0164880469.USD","BK1536","BK1610","LU1497733557.USD","LU1634259557.SGD","LU0164865239.USD","LU1497734951.SGD","LU1226287529.USD"],"gpt_icon":0},{"id":"2540068247","title":"ANTA Sports Products Limited Announces New Share Award Scheme Granting 10.45 Million Shares to Employees","url":"https://stock-news.laohu8.com/highlight/detail?id=2540068247","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540068247?lang=en_us&edition=fundamental","pubTime":"2025-06-04 19:33","pubTimestamp":1749036804,"startTime":"0","endTime":"0","summary":"ANTA Sports Products Limited announced a new compensation plan on June 4, 2025, involving the grant of approximately 10.45 million existing shares as part of its revised 2018 Share Award Scheme. This grant represents about 0.372% of the company's issued shares and is set to vest fully by May 1, 2028, contingent upon meeting specified performance targets. The awarded shares, which are distributed among 36 selected employees, including executive directors Mr. Lai and Mr. Wu, are offered at no purchase price. The shares will be sourced from existing shares acquired by a trustee, ensuring no new shares are issued as part of this compensation plan.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ANTA Sports Products Limited published the ori","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250604:nNDLb2VGDv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B031HY20.USD","BK1500","IE00BQXX3C00.GBP","LU0605514214.HKD","LU0463099449.HKD","IE00BGV7N243.SGD","LU0244354667.USD","LU2039709279.SGD","IE0008368742.USD","LU0048575426.USD","LU1831875114.USD","LU0052750758.USD","LU0326950275.SGD","LU0594300419.USD","LU0594300179.USD","82020","LU2177674079.SGD","LU0320764599.SGD","BK1512","ANPDY","BK1521","IE0031814852.USD","LU0048597586.USD","LU0708995583.HKD","LU0251143458.SGD","BK1227","LU0251144936.SGD","IE0008369823.USD","BK1168","LU2008162690.USD","02020","BK1589","IE00BQXX3D17.EUR","LU0650527681.SGD","IE00B031J352.USD","LU0261950470.USD","LU1188198961.HKD","BK1502","LU0261947096.USD","IE00BQXX3F31.USD","LU2488822045.USD","LU0140636845.USD"],"gpt_icon":0},{"id":"2540512880","title":"Minth Group Limited Announces New Executive Director and Changes in Independent Non-Executive Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2540512880","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540512880?lang=en_us&edition=fundamental","pubTime":"2025-06-04 17:55","pubTimestamp":1749030942,"startTime":"0","endTime":"0","summary":"Minth Group Limited has announced changes to its board of directors. Wei Ching Lien continues as Chairperson, while Mr. Chan Pak Hung and Mr. Hu Ting Wu have been appointed as independent non-executive directors. The board now includes executive directors Ms. Wei Ching Lien, Mr. Ye Guo Qiang, Ms. Zhang Yuxia, and Mr. William Chin, with Ms. Chin Chien Ya serving as a non-executive director.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Minth Group Limited published the original content used to generate this news brief on June 04, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250604:nNDL6NKv4Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1509","00425","BK1589","BK1144"],"gpt_icon":0},{"id":"2540378051","title":"China Mengniu Dairy Files Next Day Disclosure to HKEX: Repurchases 200,000 Shares for HKD 3,598,260","url":"https://stock-news.laohu8.com/highlight/detail?id=2540378051","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540378051?lang=en_us&edition=fundamental","pubTime":"2025-06-04 17:46","pubTimestamp":1749030364,"startTime":"0","endTime":"0","summary":"China Mengniu Dairy Company Limited has submitted a Next Day Disclosure Return to the Hong Kong Stock Exchange, reporting the repurchase of 200,000 shares at an aggregate price of HKD 3,598,260. The repurchase was made in accordance with the Main Board Rules, with the repurchased shares set for cancellation.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China Mengniu Dairy Company Limited published the original content used to generate this news brief on June 04, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250604:nNDL7HDJKQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B0169L03.USD","IE00B031HY20.USD","LU0471298777.SGD","IE00B067MR52.USD","LU0385154629.USD","LU1051768304.USD","LU0370786039.SGD","LU0228367735.SGD","HK0000320223.HKD","LU1023057109.AUD","LU2045819591.USD","BK1597","BK1521","LU0307460666.USD","LU0359201612.USD","LU0543330483.HKD","LU0106959298.USD","LU0320764755.SGD","LU0228659784.USD","LU0359201885.HKD","LU0672654166.SGD","HK0000306685.HKD","LU0211977185.USD","LU0328353924.USD","IE0008368742.USD","BK1237","LU0072462343.USD","IE00B031J352.USD","LU0259732245.USD","LU0173614495.USD","BK1589","LU0287142896.SGD","LU0737861699.HKD","LU1769817179.HKD","LU0650527681.SGD","LU1048588211.SGD","LU1102505929.USD","LU0348788117.USD","IE0009570106.USD","BK1553","IE0032834883.USD","IE0008369823.USD","02319","SG9999002828.SGD","LU0048580855.USD","LU0128522157.USD","LU0315179316.USD","LU1102505762.USD","HK0000306701.USD","LU0326950275.SGD"],"gpt_icon":0},{"id":"2540059896","title":"Shandong Weigao Group Medical Polymer Co. Ltd. Buys Back 140,000 Shares for HKD 800,800","url":"https://stock-news.laohu8.com/highlight/detail?id=2540059896","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540059896?lang=en_us&edition=fundamental","pubTime":"2025-06-04 17:33","pubTimestamp":1749029615,"startTime":"0","endTime":"0","summary":"Shandong Weigao Group Medical Polymer Co. Ltd. announced a buyback transaction, repurchasing approximately 140,000 units as treasury shares at a price of 5.72 HKD per unit. The aggregate price paid for the repurchase was approximately 800,800 HKD.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shandong Weigao Group Medical Polymer Co. Ltd. published the original content used to generate this news brief on June 04, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250604:nNDLc9vWDd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01066","LU0287142896.SGD","LU0173614495.USD","BK1222","BK1589"],"gpt_icon":0},{"id":"2540308360","title":"Indonesian policyholders must pay part of medical insurance claims from 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2540308360","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540308360?lang=en_us&edition=fundamental","pubTime":"2025-06-04 16:24","pubTimestamp":1749025458,"startTime":"0","endTime":"0","summary":"Indonesian policyholders must pay part of medical insurance claims from 2026JAKARTA, June 4  - Starting next year, Indonesian policyholders will have to bear some of the cost of their hospital bills through co-payment, according to a new regulation intended to curb overclaims and curb a rise in medical costs.Under the new rules, policyholders will have to pay at least 10% of their total claim or a maximum of 300,000 rupiah  for outpatient care and 3 million rupiah  for inpatient care.Indonesia's Financial Services Authority  said the regulations were a response to a significant increase in insurance claims due to the higher cost of health services. It did not say by how much claims had risen.The rule was also to prevent moral hazard and overtreatment, OJK added. \"If this continues, we fear the sustainability of the health insurance business could be disrupted,\" OJK said in a statement this week. Indonesia's medical insurance industry is dominated by foreign players, including Prudentia","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250604:nL3N3S70H5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1589","LU0149721374.USD","LU0197773673.USD","LU0955669360.SGD","LU0588545904.SGD","LU0918141705.HKD","LU1102505929.USD","LU0856984785.SGD","LU0140636845.USD","LU0132412106.USD","81299","LU1152091168.USD","IE0031814852.USD","LU1282648689.USD","LU0819123356.HKD","SG9999014039.USD","LU0043850808.USD","AAGIY","LU0029875118.USD","LU0577902538.SGD","LU1201861165.SGD","LU0251144936.SGD","SG9999014013.SGD","LU0823038988.USD","PRU.UK","LU0096374516.USD","LU0345776255.USD","IE0032834883.USD","LU2008162690.USD","IE00B3T34201.USD","LU0607220059.USD","LU2491050071.SGD","LU0541502299.USD","LU1880383440.USD","SG9999002463.SGD","01299","LU0048580855.USD","LU0348814723.USD","LU0823426308.USD","LU0067412154.USD","LU0348788117.USD","LU2152927971.USD","LU0577902611.USD","LU0345775950.USD","LU0048575426.USD","LU0828238088.HKD","LU1880383366.USD","LU0979878070.USD","LU0348735423.USD","LU0048388663.USD"],"gpt_icon":0},{"id":"2540799031","title":"Innovent's Phase 1 Trial for Lung Cancer Drug Shows Manageable Safety, Long-Term Survival Benefits; Shares Surge 14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2540799031","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540799031?lang=en_us&edition=fundamental","pubTime":"2025-06-04 15:10","pubTimestamp":1749021006,"startTime":"0","endTime":"0","summary":"Innovent Biologics'  IBI363 medication for immunotherapy-resistant non-small cell lung cancer and wild-type lung adenocarcinoma showed a manageable safety profile, efficacy, and long-term survival benefits during its phase 1 study.The drug company presented the findings during the 2025 American Society of Clinical Oncology Conference, according to a Wednesday news release.IBI363 also showed breakthrough therapeutic potential from tumor response to long-term survival benefits for patients with immuno-resistant squamous non-small cell lung cancer, and wild-type lung adenocarcinoma, especially with those who smoked.Shares surged 14% during Wednesday's afternoon trading.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1969619763.USD","BK1161","LU2488822045.USD","BK1583","BK1589","LU2328871848.SGD","01801"],"gpt_icon":0},{"id":"2540350010","title":"BUZZ-Hansoh hits near 4-year peak as its cancer drug gets UK marketing approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2540350010","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540350010?lang=en_us&edition=fundamental","pubTime":"2025-06-04 13:49","pubTimestamp":1749016175,"startTime":"0","endTime":"0","summary":"BUZZ-Hansoh hits near 4-year peak as its cancer drug gets UK marketing approval ** Shares of Hansoh Pharmaceutical Group 3692.HK rise 3.8% to HK$27.5, their highest levels since August 2021** Stock marks biggest intraday pct gain since May 20, and on track for a third straight session of rise, if current trend holds ** Stock is fifth-biggest pct gainer on the Hang Seng Commerce & Industry Index .HSNC, which climbs 0.8% ** Hansoh says its innovative drug Aumolertinib Mesilate Tablets for lung cancer has been approved by the Medicines and Healthcare Products Regulatory Agency  in the UK for marketing** The Hang Seng Biotech Index .HSHKBIO rises 3.1% and the Hang Seng Index .HSI adds 0.5%** YTD, stock up 56.8%  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250604:nL2N3S704L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","03692","BK1589","BK1583"],"gpt_icon":0},{"id":"2540038640","title":"Hansoh Pharmaceutical's Aumolertinib Mesilate Tablets Approved by UK MHRA for Marketing","url":"https://stock-news.laohu8.com/highlight/detail?id=2540038640","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540038640?lang=en_us&edition=fundamental","pubTime":"2025-06-04 12:08","pubTimestamp":1749010133,"startTime":"0","endTime":"0","summary":"Hansoh Pharmaceutical Group Co. Ltd. has announced that its innovative drug, Aumolertinib Mesilate Tablets , has been approved by the Medicines and Healthcare Products Regulatory Agency  in the United Kingdom for marketing. Aumseqa is indicated for the first-line treatment of adult patients with locally advanced or metastatic non-small cell lung cancer  with activating epidermal growth factor receptor  mutations, and for the treatment of adult patients with locally advanced or metastatic EGFR T790M mutation-positive NSCLC. This approval marks a significant milestone for Hansoh Pharmaceutical as it expands its presence in the UK market with its first innovative third-generation EGFR-TKI drug developed in China.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investm","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250604:nNDL72BkFW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03692","BK1589","BK1191","BK1583"],"gpt_icon":0},{"id":"2540038637","title":"Hansoh Pharmaceutical - Aumolertinib Mesilate Tablets Was Approved by Mhra for Marketing","url":"https://stock-news.laohu8.com/highlight/detail?id=2540038637","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540038637?lang=en_us&edition=fundamental","pubTime":"2025-06-04 12:06","pubTimestamp":1749009993,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250604:nFWN3S702S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["03692","BK1191","BK1589","BK1583"],"gpt_icon":0},{"id":"2540772637","title":"Zhongyu Energy Holdings Limited Announces Executive Management Changes: Li Yan Resigns, Peng Jun and Wang Jichao Appointed","url":"https://stock-news.laohu8.com/highlight/detail?id=2540772637","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540772637?lang=en_us&edition=fundamental","pubTime":"2025-06-03 22:08","pubTimestamp":1748959738,"startTime":"0","endTime":"0","summary":"Zhongyu Energy Holdings Limited has announced changes in its executive management, effective from June 3, 2025. Mr. Li Yan will resign as an executive director due to health reasons and retirement. Mr. Peng Jun and Mr. Wang Jichao have been appointed as new executive directors.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zhongyu Energy Holdings Limited published the original content used to generate this news brief on June 03, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250603:nNDL5xsZmQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03633","BK1500","LU1115378108.SGD","00384","BK1589","BK1566","BK1221","LU0640798160.USD"],"gpt_icon":0},{"id":"2540779995","title":"Sino Biopharm Presents Lung Cancer Study Data at American Oncology Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2540779995","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540779995?lang=en_us&edition=fundamental","pubTime":"2025-06-03 19:59","pubTimestamp":1748951972,"startTime":"0","endTime":"0","summary":"Sino Biopharmaceutical  presented the latest results of the phase III clinical study for benmelstobart injection in combination with anlotinib hydrochloride capsules at the American Society of Clinical Oncology's annual meetingThe drug is being tested as first-line treatment for non-small cell lung cancer in comparison with the pembrolizumab injection.The study has achieved the primary study endpoint of progression-free survival, in which the median survival was prolonged by more than 6 months in the population with TPS ≥50%.There was also a 40% reduction in the risk of disease progression and death as compared with the arm of pembrolizumab.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BZ08YR35.GBP","BK1589","AFG","BK1521","IE00BZ08YS42.EUR","BK1191","01177","IE00BZ08YT58.USD","BK1515","BK4107","BK4117"],"gpt_icon":0},{"id":"2540330779","title":"Xinyi Solar Holdings Ltd. Announces Proposed PRC Listing for Selected Solar Farm Projects via Infrastructure REIT","url":"https://stock-news.laohu8.com/highlight/detail?id=2540330779","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540330779?lang=en_us&edition=fundamental","pubTime":"2025-06-03 19:50","pubTimestamp":1748951429,"startTime":"0","endTime":"0","summary":"Xinyi Solar Holdings Ltd. has announced a proposed PRC listing of selected solar farm projects through a Solar Farm Infrastructure REIT. The company, which is listed on the Hong Kong Stock Exchange under stock code 00968, aims to enhance its investment portfolio with this initiative. Further announcements will be made as the process progresses, subject to market conditions and regulatory approvals in Hong Kong and the PRC.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xinyi Solar Holdings Ltd. published the original content used to generate this news brief on June 03, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250603:nNDLc3ggbr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ08YT58.USD","BK1589","BK1169","IE00BZ08YR35.GBP","LU1983299162.USD","BK1554","IE00BZ08YS42.EUR","00968"],"gpt_icon":0},{"id":"2540402767","title":"China's Xiaomi Founder Expects EV Business to Turn Profitable in H2","url":"https://stock-news.laohu8.com/highlight/detail?id=2540402767","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540402767?lang=en_us&edition=fundamental","pubTime":"2025-06-03 15:58","pubTimestamp":1748937512,"startTime":"0","endTime":"0","summary":"BEIJING, June 3 (Reuters) - China's Xiaomi founder and CEO Lei Jun said on Tuesday that he expected the company's auto business to turn profitable in the second half the year, according to a company spokesperson.Hong Kong-listed shares of Xiaomi jumped 3%.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"1b3c18c892beda1e121bf03bd464ec45","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250603:nP8N3Q2054:1","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Xiaomi Founder Expects EV Business to Turn Profitable in H2","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2476274720.SGD","LU0359202008.SGD","LU0588546209.SGD","SG9999001093.SGD","LU0143863198.USD","LU0823397285.USD","LU0307460666.USD","SG9999002463.SGD","LU1481107354.HKD","LU0348827113.USD","SG9999003461.SGD","LU0797268264.HKD","LU0417516738.SGD","LU0235996351.USD","LU0348814723.USD","BK1589","01810","LU2778985437.USD","LU0164880469.USD","LU0611395673.USD","LU1868838027.USD","BK1193","IE0034224299.USD","LU2097828805.USD","LU0540923850.HKD","LU0143863784.USD","LU2226246903.HKD","LU0918141705.HKD","BK1521","LU0531971595.HKD","LU0823038988.USD","XIACY","LU0164865239.USD","LU0039217434.USD","LU0871576103.HKD","BK1615","LU1720050803.USD","LU1981816686.USD","LU1868837565.USD","LU1770036033.HKD","LU0823413660.USD","LU1770034418.SGD","LU1880383366.USD","LU2399975544.HKD","LU0211977185.USD","LU0823426308.USD","LU0359201885.HKD"],"gpt_icon":1},{"id":"2540740110","title":"China's Xiaomi:Founder Expects Xiaomi's Auto Business to Turn Profitable in H2","url":"https://stock-news.laohu8.com/highlight/detail?id=2540740110","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540740110?lang=en_us&edition=fundamental","pubTime":"2025-06-03 15:29","pubTimestamp":1748935754,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"1b3c18c892beda1e121bf03bd464ec45","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250603:nP8N3Q2054:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MIUmain","LU0572944931.SGD","LU0823397285.USD","LU1794554557.SGD","BK1589","LU0417516738.SGD","LU0348827113.USD","HXXD.SI","LU0823039010.USD","LU0149721374.USD","BK1523","LU0499858602.USD","LU1813983027.USD","LU1105468828.SGD","BK1521","BK1575","LU1719994722.HKD","IE0032431581.USD","LU0918141705.HKD","LU2097828805.USD","SG9999002463.SGD","LU0634319403.HKD","LU0307460666.USD","81810","LU0359201612.USD","LU0561508036.HKD","LU1481107354.HKD","LU2226246903.HKD","LU2476274720.SGD","LU0359201885.HKD","LU0348735423.USD","LU0823397103.USD","LU1868838027.USD","LU0348814723.USD","LU2087589342.USD","LU1770036033.HKD","LU0143863784.USD","LU0823038988.USD","IE0034224299.USD","LU1981816686.USD","LU0052750758.USD","LU0235996351.USD","BK1193","LU0540923850.HKD","LU0593848301.USD","LU1770034418.SGD","XIACY","01810","LU2097828714.EUR","LU2778985437.USD"],"gpt_icon":0},{"id":"2540741249","title":"Market Chatter: Macau's Hotel Room Shortage Hinders City's Growth, Galaxy Chairman Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2540741249","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540741249?lang=en_us&edition=fundamental","pubTime":"2025-06-03 13:34","pubTimestamp":1748928882,"startTime":"0","endTime":"0","summary":"A lack of hotel rooms in Macau is impeding its diversification from a gaming-focused economy to a mass-market-driven model, the South China Morning Post reported Monday, citing Galaxy Entertainment  Chairman Francis Lui Yiu-tung.The city needs improvements, especially an additional 15,000 hotel rooms priced below HK$1,000, and better policies surrounding the development of nearby Hengqin Island, China, to help solve the problem, the report said, citing Lui.In 2024, Macau welcomed 35 million visitors and had 45,000 rooms. In comparison, Las Vegas has 160,000 rooms and welcomed 40 million visitors, the report said.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["00027","BK1521","LU0488056044.USD","LU0384037296.USD","LU0417516571.SGD","BK1610","CHCO","LU1880383366.USD","BK1589","LU0702159699.USD","LU0348784397.USD","LU0650527681.SGD","LU0593848301.USD","HHImain","LU0211977185.USD","LU0307460666.USD","LU1166156734.SGD","LU0140636845.USD","LU0149534421.HKD","513600","MCHmain","LU0737861699.HKD","LU1282649067.USD","LU2039709279.SGD","LU1328615791.USD","LU0821914370.USD","LU0348783233.USD","LU1282649810.SGD","HSI","LU0287142896.SGD","LU1048596156.SGD","LU0594300419.USD","LU0326950275.SGD","LU1224709979.USD","MHImain","BK1172","LU0607220059.USD","BK4211","02833","LU0588546209.SGD","LU0173614495.USD"],"gpt_icon":0},{"id":"2540080714","title":"Innovent Biologics Announces Promising Phase 1/2 Results for IBI354 in Advanced Solid Tumors at 2025 ASCO Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2540080714","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540080714?lang=en_us&edition=fundamental","pubTime":"2025-06-03 09:00","pubTimestamp":1748912422,"startTime":"0","endTime":"0","summary":"Innovent Biologics Inc., a leading biopharmaceutical company, has announced updated clinical data for IBI354, a novel anti-HER2 antibody-drug conjugate , during the 2025 American Society of Clinical Oncology  Annual Meeting. The data, derived from a Phase 1/2 clinical study, highlights the promising anti-tumor efficacy and favorable safety profile of IBI354 across various advanced solid tumors, including ovarian and breast cancer. This study included 368 participants and demonstrated no dose-limiting toxicities at doses up to 18mg/kg, with the most common treatment-related adverse events being anemia, nausea, and a decrease in white blood cell count. The incidence of interstitial lung disease was low at 1.9% and limited to grades 1-2. These findings support Innovent's ongoing development of next-generation ADC therapies and further clinical studies are planned, including a Phase 3 study in platinum-resistant ovarian cancer.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250603:nNDL2BQ6zS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","01801","LU2488822045.USD","01911","BK1147","LU1969619763.USD","LU2328871848.SGD","BK1161","BK1589"],"gpt_icon":0},{"id":"2540719943","title":"Haidilao founder, Ray Dalio, Forrest Li’s wife among ultra-rich splurging on 8-figure Singapore properties","url":"https://stock-news.laohu8.com/highlight/detail?id=2540719943","media":"businesstimes","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540719943?lang=en_us&edition=fundamental","pubTime":"2025-06-02 23:00","pubTimestamp":1748876400,"startTime":"0","endTime":"0","summary":"Secretlab’s boss, Want Want family, Jack Ma’s wife also among super-rich buying into top-tier real estate here","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"bustime_highlight","url":"https://www.businesstimes.com.sg/property/haidilao-founder-ray-dalio-forrest-lis-wife-among-ultra-rich-splurging-8-figure-singapore-properties","rn_cache_url":null,"customStyle":"","selectors":"body","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.businesstimes.com.sg/property/haidilao-founder-ray-dalio-forrest-lis-wife-among-ultra-rich-splurging-8-figure-singapore-properties","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"bustime_highlight","symbols":["BK1591","BK1589","BK1233","BK1604","06862","LU2488822045.USD","BK1583"],"gpt_icon":0},{"id":"2540674367","title":"Hansoh Pharmaceutical Signs $80 Million License Agreement with Regeneron for Drug Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2540674367","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540674367?lang=en_us&edition=fundamental","pubTime":"2025-06-02 19:24","pubTimestamp":1748863469,"startTime":"0","endTime":"0","summary":"Hansoh Pharmaceutical Group Company Limited has announced a significant licensing agreement with Regeneron Pharmaceuticals, Inc. The agreement grants Regeneron an exclusive worldwide license, excluding the Chinese Mainland, Hong Kong, and Macau, to develop, manufacture, and commercialize HS-20094, an investigational dual GLP-1/GIP receptor agonist. The licensure will see Hansoh receiving an upfront payment of $80 million, with the potential for up to $1.93 billion in milestone payments tied to the product's development, regulatory approval, and commercialization. Additionally, Hansoh will earn double-digit royalties from potential future product sales. HS-20094 has completed multiple Phase II trials with positive results and is currently undergoing a Phase III clinical trial in China. This collaboration marks a strategic advancement for both companies in the biotechnology sector.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. Wh","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250602:nNDL8DrjnQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2468319806.SGD","LU2237438978.USD","LU0109394709.USD","LU0882574055.USD","LU0889565916.HKD","BK4588","LU2023250504.SGD","LU1974910355.USD","LU0289739699.SGD","BK4139","LU2089984988.USD","LU2362541273.HKD","BK1583","LU1917777945.USD","LU0823416689.USD","LU0114720955.EUR","03692","LU0320765992.SGD","LU0058720904.USD","LU2106854487.HKD","BK4585","LU0823434583.USD","LU2362540622.SGD","LU0053666078.USD","REGN","LU2362541513.USD","LU0823434740.USD","BK1589","BK1191"],"gpt_icon":0},{"id":"2540767822","title":"Hansoh Pharmaceutical - Licensors Will Receive an Upfront Payment of US$80 Mln and Be Eligible to Receive up to US$1.93 Bln in Milestone Payments","url":"https://stock-news.laohu8.com/highlight/detail?id=2540767822","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540767822?lang=en_us&edition=fundamental","pubTime":"2025-06-02 19:07","pubTimestamp":1748862428,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250602:nFWN3S3022:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1191","BK1589","BK1583","03692"],"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":3,"totalSize":151,"code":"91000000","status":"200"}]}}